News & Events

Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.

Isogenica Lab


Latest News


Isogenica-Phenotypeca SMART Grant Collaboration

Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award  Isogenica are collaborating with Phenotypeca, a biofoundry business who create and own yeast synthetic biology solutions...

Isogenica-PipeBio Collaboration Press Release

Isogenica announce deployment of the PipeBio Bioinformatic Cloud        Isogenica today announce that they are deploying PipeBio’s bioinformatic cloud to accelerate their drug...


Catch up on Isogenica’s latest activities.

CHI Sixth Annual Immuno-Oncology Summit Europe

Join Isogenica in London at the Annunal Immuno-Oncology SummitThe Isogenica team will be attending in person at CHI's annual Immuno-Oncology conference, taking place on 23rd-25th May....


Isogenica is excited to announce its corporate sponsorship at PEGS  November 2-4th 2021Isogenica is delighted to announce its successful attendance at PEGS Europe 2021 as Corporate Sponsors, were...


Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.

Nature Webinar

Register for Isogenica's upcoming webinar Join Isogenica for the upcoming webinar with Nature on 'VHH as building blocks for immune and tumour cell-targeting', presented by Isogenica's CSO Bill...


Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.

VHH antibodies as biotherapeutics

Camelid heavy-chain only antibodies were discovered in the early 1990’s. Often referred to as VHH antibodies, they are a well characterized alternative to therapeutic IgG’s. Camelid heavy-chain only...

read more